Andrea Blankmeyer, Chief Financial Officer of Upstart Holdings, Inc., filed a Form 4 on August 19, 2026, disclosing the disposal of common stock on August 17 and August 19, 2026, under a combination of tax-withholding sales and a Rule 10b5-1 trading plan.
Scott Darling, Chief Legal Officer of Upstart Holdings, Inc., filed a Form 4 on August 19, 2026, disclosing the sale of 814 shares of common stock on August 17, 2026, to cover tax withholding obligations related to vesting restricted stock units.
Commvault Systems Inc President and CEO Sanjay Mirchandani filed a Form 4 with the SEC on August 19, 2026, disclosing three separate sales of common stock between August 17 and August 19, 2026.
Sanjay Datta, President of Capital and Enterprise at Upstart Holdings, Inc. (NASDAQ:UPST), filed a Form 4 on August 19, 2026, disclosing the sale of 2,033 shares of common stock on August 17, 2026, to cover tax withholding obligations related to vesting restricted stock units.
Danielle Nicole Abrahamsen, Chief Accounting Officer of Commvault Systems Inc, filed a Form 4 on August 19, 2026, disclosing three separate dispositions of common stock between August 17 and August 19, 2026.
Gary Merrill, Chief Financial Officer of Commvault Systems Inc, filed a Form 4 on August 19, 2026, disclosing two sales of common stock on August 18 and August 19, 2026.
An amended statement of changes in beneficial ownership was filed on August 19, 2026, on behalf of Tyler Charles Reddien, Executive Vice President, Chief Financial Officer and Chief Operating Officer of Capri Holdings Ltd (NYSE:CPRI), correcting the reported number of restricted share units granted …
Charles R. Schwab, Co-Chairman and Director of Schwab Charles Corp (NYSE:SCHW), filed a Form 4 on August 19, 2026, disclosing two gift disposals of common stock totaling 100,050 shares on August 17 and August 18, 2026.
Nathan Blecharczyk, Chief Strategy Officer and 10% owner of Airbnb, Inc. (NASDAQ:ABNB), filed a Form 4 on August 19, 2026, disclosing transactions in Class A Common Stock and Class B Common Stock dated August 17, 2026.
A Form 4 filed on August 19, 2026 with the U.S. Securities and Exchange Commission discloses that Simon Read, a director of Dianthus Therapeutics, Inc. (NASDAQ:DNTH), exercised stock options and sold common stock on August 19, 2026 pursuant to a Rule 10b5-1 trading plan.